Propagermanium

丙帕诺

Report date: 2025/02/14 15:09:31
NME

Base Information

Drug NamePropagermanium
Drug Alias NameProxigermanium丙帕锗SerocionSK-818SK-818C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsInterleukin-1 enhancersInterleukin-2 stimulants +[8] 
TargetsInterleukin-1Interleukin-2Interferon alpha +[7] 
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1994/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSanwa Kagaku Kenkyusho Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Apptec Co LtdSuzhou Dawnrays Pharmaceutical Co LtdSanwa Kagaku Kenkyusho Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeV09X
Related LinksWikipediaKEGG